A Phase 2 double blinded, randomised, placebo controlled dose-finding study to evaluate the safety tolerability and efficacy of Volixibat potassium an apical sodium-dependant bile acid transport inhibitor (ASBTi) in adults with non-alcoholic steatohepatitis (NASH) (SHIRE Study)

1st February 2017 - ongoing

Status:

Specialism: Liver.

Team: Professor Guruprasad Aithal, Dr Rob Scott, Dr Jane Chalmers.

People

Photo	Name	Bio
	Professor Guruprasad Aithal	Biography Professor Guruprasad P. Aithal is the Professor of Hepatology and the Head of the Division for the Nottingham Digestive Diseases Centre and Deputy Director of Nottingham Molecular Pathology Node. Professor Aithal is the GI & Liver Disorder…
	Dr Rob Scott
	Dr Jane Chalmers